Magnus Schou Selected Research

Isotopes

1/2021

Multiple Applications of a Novel Biarsenical Imaging Probe in Fluorescence and PET Imaging of Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magnus Schou Research Topics

Disease

6	Neoplasms (Cancer) 02/2024 - 01/2020
5	Brain Neoplasms (Brain Tumor) 11/2023 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 03/2012
2	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2024 - 12/2021
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2021
2	Migraine Disorders (Migraine) 01/2020 - 01/2019
2	Epilepsy (Aura) 01/2020 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2020
2	Central Nervous System Diseases (CNS Diseases) 01/2020 - 01/2018
1	Glioma (Gliomas) 11/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Synucleinopathies 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 12/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Multiple System Atrophy 12/2020
1	Dementia (Dementias) 12/2020
1	Proteostasis Deficiencies 12/2020
1	Autistic Disorder (Autism) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2018
1	Mental Disorders (Mental Disorder) 11/2017
1	Cognitive Dysfunction 01/2016
1	Neuralgia (Stump Neuralgia) 04/2013
1	Prodromal Symptoms 04/2013
1	Amyloid Plaque 07/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2006

Drug/Important Bio-Agent (IBA)

3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2020
3	osimertinibIBA 01/2023 - 01/2020
2	AZD1390IBA 02/2024 - 12/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2020
2	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 01/2016
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 11/2017
2	5-HT1B Serotonin ReceptorIBA 01/2019 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 04/2013 - 03/2012
1	Radiation-Sensitizing AgentsIBA 02/2024
1	Phosphotransferases (Kinase)IBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 11/2023
1	MethyltransferasesIBA 11/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	GTP Phosphohydrolases (GTPases)IBA 01/2023
1	Codon (Codons)IBA 01/2023
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2023
1	CrizotinibIBA 12/2022
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	AfatinibIBA 01/2021
1	IsotopesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Type 1 Melanocortin ReceptorIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	SynucleinsIBA 12/2020
1	GangliosidesIBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020
1	Insulin (Novolin)FDA Link 12/2018
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2018
1	N,N- dimethyl- 7- (4- (2- (pyridin- 2- yl)ethyl)piperazin- 1- yl)benzofuran- 2- carboxamideIBA 01/2016
1	benzofuranIBA 01/2016
1	2- (6- (methylamino)pyridin- 3- yl)- 1,3- benzothiazol- 6- olIBA 04/2013
1	N- (2- tert- butyl- 1- ((4,4- difluorocyclohexyl)methyl)- 1H- benzo(d)imidazol- 5- yl)ethanesulfonamideIBA 04/2013
1	AZD2995IBA 04/2013
1	LigandsIBA 07/2012
1	flutemetamolIBA 07/2012
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 09/2006
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 09/2006

Therapy/Procedure

2	Therapeutics 01/2020 - 04/2013
1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 12/2021